Skip to main content

EpiPen Maker Mylan Gives 'Generous' Executive Pay

Mylan dealing with more negative reports, this time for executive pay.

Mylan (MYL) - Get Viatris, Inc. Report is dealing with more negative reports on executive pay. The company, which has come under fire for the price of the life-saving EpiPen, has the second-highest executive compensation package in the industry, according to the Wall Street Journal. Over the past five years, Mylan has paid its top five managers a total of nearly $300 million. That figure is surprising because Mylan isn't that large of a company. The drug maker ranks 11 in the U.S. by revenue and 16 by market cap. 

Employees of TheStreet are restricted from trading individual securities.

Scroll to Continue

TheStreet Recommends